Journal profile · Medicine-Medicine (all)
Medicina Clinica Practica
ISSN 2603-9249 · Elsevier · Spain
Medicina Clinica Practica: impact factor 2.8 (journal website); fully open access; APC about USD 1,640; review about 40 days (submission to acceptance, publisher); 44 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Medicina Clinica Practica is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Pleural and Pulmonary Diseases, Venous Thromboembolism Diagnosis and Management and Cardiac tumors and thrombi, together about 17.1% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Medicina Clínica Práctica is a new, peer reviewed, online open access journal, a companion title to the well-known and long-established Medicina Clínica . The journal is mainly focused on clinical practice and scientific communication, targeted to internists and other medical specialists. The aim of the journal is to publish articles with significant relevance in clinical practice. Sections of the journal will include case reports and clinical images, as well as reviews centered in general practice, and original research articles. The journal publishes articles in Spanish and English.Medicina Clínica Práctica es una nueva revista online, Open Access, con revisión por pares, un título que acompaña a la conocida y consolidada revista Medicina Clínica. La revista se centra principalmente en la prática clínica y la comunicación científica, dirigida a internistas y otros especialistas médicos. El objetivo de la revista es publicar artículos con relevancia significativa en la práctica clínica. Las secciones de la revista incluirán informes de casos e imágenes clínicas, así como revisiones centradas en la práctica general y artículos de investigación originales. La revista publica artículos en español y en inglés.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Medicine (all)
Editor-in-chief Albert SelvaPublisher website
Editorial board by country: none in mainland China; most named Spain 8 (8 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pleural and Pulmonary DiseasesMedicine7.2%
- Venous Thromboembolism Diagnosis and ManagementMedicine5%
- Cardiac tumors and thrombiMedicine5%
- Health and Medical EducationHealth Professions5%
- COVID-19 Clinical Research StudiesMedicine4.5%
- Dialysis and Renal Disease ManagementMedicine4.5%
- Sleep and related disordersPsychology4.5%
- Pneumothorax, Barotrauma, EmphysemaMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.8Publisher website ·
- CiteScore 2026-06
- 0.7LetPub ·
- CiteScore (publisher)
- 0.7Publisher website ·
- SJR 2026-06
- 0.18LetPub ·
- SNIP 2026-06
- 0.41LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 20OpenAlex ·
- 2-year mean citedness
- 1.11OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 509 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 30 | 30 | 0 |
| 2025 | 44 | 44 | 5 |
| 2024 | 70 | 70 | 155 |
| 2023 | 50 | 50 | 39 |
| 2022 | 41 | 41 | 58 |
| 2021 | 131 | 131 | 257 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
40 dayssubmission to acceptance · community reports about 10 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to first decision
- 17 daysPublisher website ·
- First decision after review
- 61 daysPublisher website ·
- Submission to acceptance
- 40 daysPublisher website ·
- Acceptance to publication
- 29 daysPublisher website ·
- Submission to publication (journal-reported)
- about 11 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,640 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 1,340 / EUR 1,220 / GBP 1,070 / JPY 166,200 | — | — | |
| LetPub | EUR 1,600 | Yes | — | |
| Publisher website | USD 2,050 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 4,000 words
Article types accepted5, with length limits
- original articleOriginal research about etiology, physiopathology, pathology, epidemiology, clinical aspects, diagnosis, prognosis and treatment are recommended for this sectio…main text ≤ 3,000 words · abstract ≤ 250 words · references ≤ 30
- reviewORIGINAL ARTICLESOriginal research about etiology, physiopathology, pathology, epidemiology, clinical aspects, diagnosis, prognosis and treatment are recommende…Length not stated
- review articleructured. Up to 6 authors are accepted. REVIEW ARTICLES Reviews of current work reflecting progress in various fields of medicine The text is limited to 4,200 w…main text ≤ 4,200 words · abstract ≤ 150 words · figures and tables ≤ 6
- short communicationa significant impact will be evaluated. SHORT COMMUNICATIONS The text can have a maximum of 1500 words, without including the legends of the figures or the bibl…main text ≤ 1,500 words · references ≤ 15
- surveyORIGINAL ARTICLESOriginal research about etiology, physiopathology, pathology, epidemiology, clinical aspects, diagnosis, prognosis and treatment are recommende…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Spain
- Language
- English, Spanish
- ISSN
- 2603-9249
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Medicina Clinica Practica
What is the impact factor of Medicina Clinica Practica?
The journal's website gives an impact factor of 2.8; this is the journal's own figure, as LetPub lists none for it; CiteScore 0.7, h-index 13.
How long does peer review take at Medicina Clinica Practica?
The publisher reports about 40 days (submission to acceptance); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Medicina Clinica Practica?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 4,000 words. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Medicina Clinica Practica based?
Of the 8 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Spain (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Medicina Clinica Practica?
According to LetPub and DOAJ records, Medicina Clinica Practica is indexed in Scopus and DOAJ.
Is Medicina Clinica Practica open access, and what is the APC?
Medicina Clinica Practica is a fully open-access journal. APC about USD 1,640.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .